Antithrombin III in cardiac surgery: An outcome study

Journal of Extra-Corporeal Technology

Volumn 30, Issue 4, 1998, Pages 178-183

  Conley, James C ^a   Plunkett, Patrick F ^b  

^a MAINE MEDICAL CENTER   (United States)

^b NONE

Author keywords

Antithrombin III; Cardiopulmonary bypass; Heparin resistance; Patient outcome

Indexed keywords

AMINOCAPROIC ACID; ANTITHROMBIN III; HEPARIN;

ADULT; AGED; ARTICLE; FEMALE; FIBRINOLYSIS; HEART SURGERY; HEMODILUTION; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTOPERATIVE HEMORRHAGE; REOPERATION; RETROSPECTIVE STUDY; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0032462107     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Society of Thoracic Surgeons National Cardiac Surgery Database -Incidence of complications summary first-op CAB only patients [Electronic database]. Chicago, IL: Society of Thoracic Surgeons [Producer and Distributor]. 1996.
2. Fedoruk, L.M., Stewart, K.M., Hayden, R.I. 1993. The cardiac surgery program at Royal Columbian Hospital: Review of the first fiscal year. Can J Surg. 1993; 36:541-545.
3. Magovern, G.J. Sr., Magovern G.J. Jr. A model for predicting transfusion after coronary artery surgery grafting. Ann Thorac Surg. 1996; 61: 27-32.
4. Lacritz, E.M., Satten, G.A., Aberle-Grasse, J., Dodd, R,Y., Raimond, V.P., Janssen, R.S., Lewis, W. F., Notari, E.P., Petersen, L.R.. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med. 1995; 333: 1721-1725.
5. Shahian, D.M., Weiner, N.J., Kurtz, S.R. Anti JKb delayed hemolytic transfusion reactions after cardiopulmonary bypass. Panminerva Med 1995; 37: 95-97
6. Vamvakas, E.C., Moore, S. B. Blood transfusion and post-operative septic complications. Transfusion, 1994: 34: 714-727.
7. Harker, L.F. Bleeding after cardiopulmonary bypass. N Engl J of Med. 1986; 314: 1446-1448.
8. Zilla, P., Fasol, R., Groscurth, P., Klepetko, W., Reichenspunuer, H., Wolner, E. Blood platelets in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg. 1989: 97: 379-388.
9. Campbell, F.W. The contribution of platelet dysfunction to postbypass bleeding. J Cardiothorac Vasc Anes. 1991; 5 (Suppl 1): 8-12.
10. Wenger, R.K., Lukasiewicz, H., Mikuta, B.S., Niewiarowski, S., Edmunds, L.H. Loss of platelet fibrinogen receptors during clinical cardioplmonary bypass. J Thorac Cardiovasc Surg. 1989; 97: 235-239.
11. Øvrum, E., Åm Holen E., Tangen, G., Broosstad, F., Abdelnoor, M., Ringdal, M.L., Øystese, R., Istad, R. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effects. Ann Thorac Surg. 1995; 60:365-71.
12. van Oeveren, W., Eijsman, L., Roozendaal, K.J., Wildevuur, Ch.R.H. Platelet preservation by aprotinin during cardiopulmonary bypass. Lancet. 1988; 1: 644.
13. Michelson, A.D., Barnard, M.R. Plasmin-induced redistribution of platelet glycoprotein Ib. Blood. 1990; 76: 2005-2010.
14. Cramer, E., Lu, H., Caen, J., Soria, C., Bemdt,M. & Tenza, D. Differential redistribution of platelet glycoproteins Ib and Iib-IIIa after plasmin stimulation. Blood.1991; 70: 694-699.
15. Colman, R,W., Marder V.J., Salzman, E.W., Hirsh, J. Overview of hemostasis. In: R.E. Colman, J. Hirsh, V.J. Marder & E.W. Salzman, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: J.B. Lippincott; 1994; 3-18.
16. Silverberg, M., Reddigari, S.R., Kaplan, A.P. . The contact system and its disorders. In: R.I. Handin, S.E. Lux, T.P. Stossel, eds. Blood: Principles and Practice of Hematology. Philadelphia, PA: J.B. Lippincott; 1995; 1140.
17. Boisclair, M.D., Land, D.A., Philippou, H., Esnouf, P., Sheikh, S., Hum, B., & Smith, J. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood. 1993; 82: 3350-3357.
18. Burman, J.F., Chung, I.P., Lane, D.A., Philippou, H., Adami, A. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet. 1994; 344: 1192-1193.
19. Heck, H.A., Lutcher, C.L., Falls, D.G. Fatal thrombocytopenic coagulopathy after cardiopulmonary bypass: Clinicopathologic correlations after cardiopulmonary bypass. South Med J. 1994; 87: 789-793.
20. Khuri, S.F., Wolfe, J.A., Josa, M., et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg. 1992; 104: 94-107.
21. Ogston, D., Murray, K., Crawford, G.P, M. Inhibition of the activated C1s subunit of the first component of complement by antithrombin III in the presence of heparin. Thromb Res.1976; 9: 217-222.
22. Rosenberg, JS., McKenna, P.W., Rosenberg, R.D. Inhibition of human factor IXa by human antithrombin. J Biol Chem. 1975; 251: 8883-8888.
23. Stead, N., Kaplan, A.P., Rosenberg, R.D. Inhibition of activated factor XII by antithrombin-heparin cofactor. J Biol Chem.1976; 251: 6481-6488.
24. Venner(d, A.M., Laake, L., Solberg, A.K. Inactivation and binding of human plasma kallikrein by antithrombin III. Thromb Res.1976; 9: 457-466.
25. Cosgriff, T.M., Bishop, D.T., Hershgold, E.J. Familial antithrombin III deficiency: Its natural history, genetics, diagnosis and treatment. Medicine. 1983; 62:209-220.
26. Irani, M.S. Antithrombin concentrates in heparin-resistant cardiopulmonary bypass patients. Clin Appl Thromb Hemost. 1996; 2: 103-106.
27. Zajtchuk, R., Collins, G.J., Schuchmann, G.F., Holley, P.W., Hamaker, W.R. Coagulation abnormalities in patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg. 1978; 75: 168-170.
28. Utley, J.R. Pathophysiology of cardiopulmonary bypass: Current issues. J Card Surg. 1990; 5: 177-189.
29. Cloyd, G.M., D'Ambra, M.N., Akins, C.W. Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting. J. Thorac Cardiovasc Surg. 1987; 94: 535-538.
30. Hashimoto, K., Yamagishi, M., Sasaki, T., Nakano, M., Kurosawa, H. Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation. Ann Thorac Surg. 1994; 58: 799-805.
31. Dietrich, W., Spannagl, M., Schramm, W., Vogt, W., Barankay, A., Richter, J.A. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;102: 505-514.
32. Friedenberg, W.R., Myers, W.O., Plotka, E.D. Platelet dysfunction associated with cardiopulmonary bypass. Ann Thorac Surg. 1978; 25: 298-305.
33. Moriau, M., Masure, R., Hurlet, A. Haemostasis disorders in open heart surgery with extracorporeal circulation. Vox Sanguinis. 1977; 32: 41-51.
34. Woodman, R.C., & Harker, L.A. Bleeding complications associated with cardiopulmonary bypass. Blood. 1990; 76: 1680-1697.